On day 7 after xenograt implantation, mice carrying palpable subcutaneous SW480 tumor xenografts received intratumorally (i.t.)or intravenously (i.v.)injections of formulated si-PRMT5. This evidence concerns the gene PRMT5 and neoplasm.